Skip to main content

Franklin Templeton — Portfolio, Page 6

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

222
Companies
$29.6B
Total invested
$130.2M
Avg. check
61
Industries
Financial Services 8FinTech 7Artificial Intelligence (AI) 6Biotechnology 5Information Technology 3Health Care 3+55 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 121144 of 222
Alto Neuroscience
March 2026

Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.

Artificial Intelligence (AI) · Los Altos$120.0M Post Ipo Equity
Utexo
March 2026

Utexo develops payment infrastructure that enables stablecoin transactions to settle directly on the Bitcoin network.

Bitcoin · Dubai$7.5M Seed
Candid Therapeutics
March 2026

Candid Therapeutics is a biotechnology company that focuses on the treatment of a range of immunological conditions.

Biotechnology · San Diego$505.0M Undisclosed
t54 Labs
February 2026

t54 Labs provides AI-driven financial services, facilitating agent-initiated transactions and comprehensive other services.

Finance · San Francisco$5.0M Seed
Crusoe
February 2026

Crusoe is a vertically integrated AI infrastructure company that builds and operates data centers powered by energy sources.

AI Infrastructure · Denver$300.0M Debt Financing
Databricks
February 2026

Databricks is a data and AI platform that unifies data engineering, analytics, and machine learning on a lakehouse architecture.

Analytics · San Francisco$2.0B Debt Financing
CesiumAstro
February 2026

CesiumAstro provides out-of-the-box communication systems for satellites, UAVs, launch vehicles, and other space or airborne platforms.

Aerospace · Austin$270.0M Series C
Nautilus Biotechnology
January 2026

Nautilus Biotechnology is a life sciences company that develops a platform for analyzing and quantifying the human proteome.

Biotechnology · San Carlos$1.6M Grant
Sentient
January 2026

Sentient builds an open-source artificial general intelligence ecosystem that supports collaborative AI research and development.

Artificial Intelligence (AI) · San FranciscoSeed
Pontoro
January 2026

Pontoro is building an automated liquidity pool platform to provide greater liquidity and access to private market assets.

Blockchain · Mountain View$5.5M Series A
Capital Markets Gateway
December 2025

CMG is a fintech firm offering an integrated digital workflow and analytics platform for capital markets professionals.

Analytics · ChicagoSeries Unknown
Jade Biosciences
December 2025

Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications.

Health Care · Waltham$45.0M Post Ipo Equity
TIFIN
December 2025

TIFIN is an AI platform that develops fintech solutions focused on tailoring investment experiences to individual needs.

Artificial Intelligence (AI) · Boulder$3.0M Series Unknown
T1 Energy
December 2025

T1 Energy is a solar and battery manufacturing company for commercial and industrial sectors.

Battery · Austin$140.0M Post Ipo Equity
Galaxy Digital
December 2025

Galaxy Digital is a technology-driven investment firm that provides financial solutions spanning the digital assets ecosystem.

Asset Management · New York$50.0M Post Ipo Debt
Dyne Therapeutics
December 2025

Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.

Biotechnology · Cambridge$402.5M Post Ipo Equity
Micruity
December 2025

Micruity is a finance and insurance company that provides services in retirement, annuity, pension, insurance, insurtech, and fintech.

Financial Services · Toronto$20.0M Series A
Revolut
November 2025

Revolut is a financial technology company that offers banking services, money transfers, foreign exchange, and spending analytics.

Banking · LondonSecondary Market
Keyper
November 2025

Keyper is a digital real estate management platform that offers monitoring real estate portfolios and access data-driven insights.

Advice · DubaiCorporate Round
Centessa Pharmaceuticals
November 2025

Centessa Pharmaceuticals is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process.

Biotechnology · Cambridge$250.0M Post Ipo Equity
Blaize
November 2025

Blaize is an AI computing platforms company that develops products for the automotive, smart vision, and enterprise computing markets.

Artificial Intelligence (AI) · El Dorado Hills$30.0M Post Ipo Equity
Redwood Materials
October 2025

Redwood Materials is a battery recycling startup that makes electric vehicles and sustainable materials for circular supply chains.

Advanced Materials · Carson City$425.0M Series E
Deel
October 2025

Deel offers a unified platform that supports payroll, HR, compliance, and workforce management across global teams.

Bookkeeping and Payroll · San Francisco$300.0M Series E
Barton Gold
October 2025

Barton Gold is a gold exploration company that focuses on exploration in two large-scale mineral systems.

Mining · Adelaide$15.0M Post Ipo Equity

Where Franklin Templeton invests

Financial Services8
FinTech7
Artificial Intelligence (AI)6
Biotechnology5
Information Technology3
Health Care3

About Franklin Templeton's portfolio

How many companies has Franklin Templeton invested in?

Franklin Templeton has invested in 222 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Franklin Templeton invest in?

Franklin Templeton's top investment sectors include Financial Services, FinTech, Artificial Intelligence (AI), Biotechnology, Information Technology. The firm invests across 61 different industry categories.

What is Franklin Templeton's largest investment?

Among tracked funding rounds, Databricks received $2.0B in a Debt Financing round. Franklin Templeton's total known invested capital is $29.6B.

What is the average investment size for Franklin Templeton?

Franklin Templeton's average investment size is $130.2M across its portfolio of 222 companies.

What are Franklin Templeton's most recent investments?

Recent Franklin Templeton portfolio additions include Alto Neuroscience, Utexo, Candid Therapeutics, t54 Labs, Crusoe. These companies were founded in 2020 or later.

Reach the founders behind these 222 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →